Merck EBRGs Receive Diversity Best Practices Awards for Their Impact on the Community and Workplace

Merck is honored that two of their Employee Business Resource Groups (EBRGs) were recently recognized by Diversity Best Practices for the work they do to drive diversity, equity and inclusion with the company and in the communities in which we...

CNH Industrial Brands Supporting Sustainable Mechanized Cotton Harvest in Uzbekistan

From the start of the COVID-19 pandemic, CNH Industrial N.V. and its brands have found innovative solutions to overcome unprecedented challenges in order to deliver mission critical equipment the world over.

Johnson & Johnson Announces European Commission Approval for Janssen's Preventive Ebola Vaccine

On July 1, Johnson & Johnson announced that the European Commission (EC) has granted Marketing Authorisation for its Janssen Pharmaceutical Companies’ Ebola vaccine regimen for the prevention of Ebola Virus Disease.

Anheuser-Busch's Sustainability Challenge: 20 Million Empty Miles

Filling Anheuser-Busch’s backhauls poses a challenge and a massive opportunity for efficiency gains and reduced environmental impact. Every year, Slaughter said, A-B has 20 million empty miles in its dedicated fleet that need to be filled with freight.

Healthy People/Healthy Planet: Complimentary or Contradictory?

As we enter into the beginning stages of rebound and recovery, how can we ensure that our decisions are in balance for people and planet? Join us for an upcoming webcast discussion with the World Economic Forum’s...

Anti-Virus: Infor Software is Helping Hospitals Battle the COVID-19 Pandemic

The COVID-19 pandemic has put normal life on pause for many, including Matt Wilson. Quarantined at home in Kansas City, Wilson – senior vice president of healthcare strategy with global cloud software company Infor – felt sidelined, powerless to help in the fight.

Relief From Sickle Cell Disease Made Possible by Red Cross and FedEx

If you could, with relative ease, relieve someone else’s physical suffering from an agonizing blood disorder, would you?

Increasing Diversity in Clinical Trials: A Collaboration with Tufts Center for the Study of Drug Development

At Biogen, we are committed to putting the weight of our business, our employees, and our collaboration partners to help close the disparity gap in clinical trials and access to healthcare.

Fifth Third's Jeff Korzenik Provides Update on COVID-19's Market Impact

Fifth Third’s Chief Investment Strategist Jeff Korzenik comments on FOX Business about the COVID-19 pandemic and other factors affecting global markets.